Adient (NYSE:ADNT) is back in focus after recent analyst coverage flagged profitability pressures in Europe, even as the company lifted annual sales guidance following fiscal Q1 results that topped revenue and EPS estimates.
See our latest analysis for Adient.
The recent analyst caution and mixed guidance appear to be weighing on sentiment in the short term, with a 30 day share price return of 18.52% and a 7 day share price return of a 4.29% decline, even though the 1 year total shareholder return of 51.72% contrasts with weaker 3 and 5 year total shareholder returns. This suggests that momentum has been choppy rather than consistently building.
If Adient’s recent swings have you thinking about where else capital could work harder, this might be a good moment to look at 20 top founder-led companies as another source of ideas.
With Adient shares at US$21.21, a stated intrinsic discount of about 70% and a large gap to the average analyst price target, the key question is whether this reflects mispricing or whether markets are already baking in any future recovery potential.
Most Popular Narrative: 15.3% Undervalued
With Adient last closing at $21.21 against a narrative fair value of $25.05, the current pricing sits well below what the most followed thesis implies.
Operational efficiencies through automation, restructuring, and portfolio optimization are set to deliver meaningful cost savings, particularly in Europe where the roll off of underperforming contracts and new higher margin program launches are expected to raise regional EBITDA margins to mid single digits over the next 2 3 years, supporting overall net earnings.
Curious what kind of revenue path and margin rebuild sit behind that fair value, and how a lower future earnings multiple still supports it? The full narrative lays out the cash flow curve, the implied profitability shift, and the valuation bridge that connects today’s share price to that $25.05 figure.
Result: Fair Value of $25.05 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there are still clear pressure points, including margin weakness in Europe and volume and mix uncertainty in EMEA and China, that could upset this fair value story.
Find out about the key risks to this Adient narrative.
Next Steps
If the mixed signals here leave you on the fence, this is a good time to look at the numbers yourself and move quickly on your own view, starting with 3 key rewards.
Ready to size up more opportunities?
If this story has sharpened your thinking, do not stop here. Use the Simply Wall St screener to pressure test other ideas before you commit fresh capital.
- Spot potential value cues early by scanning our set of 50 high quality undervalued stocks that currently screen well on quality and pricing metrics.
- Prioritize resilience by filtering for companies in the 67 resilient stocks with low risk scores so you can focus on businesses with fewer flagged risk factors.
- Hunt for tomorrow’s potential leaders with a screener containing 23 high quality undiscovered gems that the wider market may not be paying close attention to yet.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com